Cargando…
Chemotherapy, host response and molecular dynamics in periampullary cancer: the CHAMP study
BACKGROUND: Pancreatic cancer is a devastating disease with a dismal prognosis. Despite profound medical advances in systemic therapies for other types of aggressive tumours during recent years, a diagnosis of pancreatic cancer is still often synonymous with a fatal outcome. The term periampullary c...
Autores principales: | Hau, Sofie Olsson, Petersson, Alexandra, Nodin, Björn, Karnevi, Emelie, Boman, Karolina, Williamsson, Caroline, Eberhard, Jakob, Leandersson, Karin, Gisselsson, David, Heby, Margareta, Jirström, Karin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161011/ https://www.ncbi.nlm.nih.gov/pubmed/32293352 http://dx.doi.org/10.1186/s12885-020-06807-3 |
Ejemplares similares
-
Mutational Landscape in Resected Periampullary Adenocarcinoma: Relationship With Morphology and Clinical Outcome
por: Lundgren, Sebastian, et al.
Publicado: (2019) -
Sex and gender differences in treatment intention, quality of life and performance status in the first 100 patients with periampullary cancer enrolled in the CHAMP study
por: Olsson Hau, Sofie, et al.
Publicado: (2023) -
Prognostic and predictive significance of podocalyxin-like protein expression in pancreatic and periampullary adenocarcinoma
por: Heby, Margareta, et al.
Publicado: (2015) -
The clinical importance of tumour-infiltrating macrophages and dendritic cells in periampullary adenocarcinoma differs by morphological subtype
por: Lundgren, Sebastian, et al.
Publicado: (2017) -
Trajectories of immune-related serum proteins and quality of life in patients with pancreatic and other periampullary cancer: the CHAMP study
por: Hau, Sofie Olsson, et al.
Publicado: (2023)